Form 8-K - Current report:
SEC Accession No. 0001564590-20-041552
Filing Date
2020-08-27
Accepted
2020-08-27 16:34:45
Documents
15
Period of Report
2020-08-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K082020 asmb-8k_20200827.htm   iXBRL 8-K 39102
2 EX-99.1 asmb-ex991_15.htm EX-99.1 26888
3 GRAPHIC gc2gqp0y0l32000001.jpg GRAPHIC 2994
4 GRAPHIC gc2gqp0y0l32000002.jpg GRAPHIC 3107
  Complete submission text file 0001564590-20-041552.txt   208246

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA asmb-20200827.xsd EX-101.SCH 5788
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20200827_lab.xml EX-101.LAB 18731
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20200827_pre.xml EX-101.PRE 11182
8 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20200827_htm.xml XML 3444
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 201143298
SIC: 2834 Pharmaceutical Preparations